Observational Study of Approaches to Lipid-lowering Therapy in Russian Patients With Coronary Heart Disease (<<Treat to Goal>>).
Phase of Trial: Phase IV
Latest Information Update: 16 Sep 2014
At a glance
- Drugs Ezetimibe; HMG-CoA reductase inhibitors
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Schering-Plough
- 18 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Aug 2009 Planned end date changed from 1 Jul 2009 to 1 Aug 2009 as reported by ClinicalTrials.gov.